| There were not enough data from the trial to conclude on how well Vaxzevria works for people who have already had COVID-19 | If, later on, the person comes into contact with SARS-CoV-2 virus, their immune system will recognise it and be ready to defend the body against it |
|---|---|
| Department of Health and Social Care | Coleman, Justine 10 June 2020 |
Belluz, Julia 23 November 2020.
| The Agency based its calculation of how well the vaccine worked on the results from study COV002 conducted in the UK and study COV003 conducted in Brazil | Mallapaty, Smriti; Callaway, Ewen 2021-03-24 |
|---|---|
| Lymphadenopathy enlarged lymph nodes , decreased appetite, dizziness, sleepiness, lethargy lack of energy , sweating, abdominal belly pain, itching, rash and urticaria itchy rash may affect up to 1 in 100 people | "A Phase III study to investigate a vaccine against COVID-19" |
Thrombocytopenia low levels of blood platelets , vomiting, diarrhoea, pain in legs or arms, swelling and redness at the injection site, flu-like illness and asthenia weakness may affect up to 1 in 10 people.
14